XML 90 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2012
Computation Of Basic And Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (“EPS”) (shares in millions):

 

     Three Months  Ended
September 30,
     Nine Months Ended
September 30,
 
     2012      2011      2012      2011  

Net income for basic EPS

   $ 280       $ 82       $ 336       $ 141   

Convertible note interest, net of tax

     1         2         4         5   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income for diluted EPS

     281         84         340         146   
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic weighted average shares outstanding

     106.8         105.4         106.5         105.1   

Options, warrants and non-vested stock

     2.3         2.3         2.2         2.6   

Convertible debt

     8.9         21.2         14.0         21.2   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted weighted average shares outstanding

     118.0         128.9         122.7         128.9   
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per share:

           

Basic

   $ 2.62       $ 0.78       $ 3.16       $ 1.34   

Diluted

   $ 2.38       $ 0.65       $ 2.77       $ 1.14   
Outstanding Common Stock Equivalents That Were Anti-Dilutive

The following table summarizes the Company’s outstanding common stock equivalents that were anti-dilutive and therefore excluded from the computation of diluted EPS:

 

     Three Months  Ended
September 30,
     Nine Months  Ended
September 30,
 
     2012      2011      2012      2011  

Options (a)

     0.2         1.1         0.2         1.2   

Warrants (b) (c)

     8.9         21.2         8.9         21.2   

 

(a) 

The weighted average exercise price for anti-dilutive options for the three and nine months ended September 30, 2012 was $17.17 and $16.35, respectively. For the three and nine months ended September 30, 2011, the weighted average exercise price for anti-dilutive options was $24.59.

(b) 

Represents all outstanding warrants as of September 30, 2012 and 2011, which had an exercise price of $22.50.

(c) 

The decrease in the number of warrants underlying the 3 1/2% convertible notes that were anti-dilutive was related to the Company’s repurchase of a portion of its 3 1/2% convertible notes and warrants (see Note 11—Long-term Debt and Borrowing Arrangements and Note 14—Stockholders’ Equity for more information).